| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 42 |
| 1 | DEXAMETHASONE 1.5 MG | 42 |
| 2 | VENETOCLAX | 33 |
| 3 | BORTEZOMIB | 30 |
| 4 | DARATUMUMAB | 25 |
| 5 | LENALIDOMIDE | 25 |
| 6 | ETOPOSIDE | 21 |
| 7 | RITUXIMAB | 20 |
| 8 | CARBOPLATIN | 19 |
| 9 | METHOTREXATE | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ILOPROST | 1 | 0.0011 |
| 1 | CARMUSTINE | 5 | 0.0011 |
| 2 | NELARABINE | 1 | 0.0010 |
| 3 | OBINUTUZUMAB | 14 | 0.0008 |
| 4 | IFOSFAMIDE FOR INJECTION | 16 | 0.0007 |
| 5 | TEMOZOLOMIDE | 14 | 0.0007 |
| 6 | THIOTEPA | 6 | 0.0006 |
| 7 | VENETOCLAX | 33 | 0.0005 |
| 8 | CEFTAZIDIME | 4 | 0.0005 |
| 9 | MELPHALAN HYDROCHLORIDE | 13 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 45 |
| 1 | BCL-2 Inhibitor [EPC] | 33 |
| 2 | Proteasome Inhibitor [EPC] | 32 |
| 3 | Alkylating Drug [EPC] | 31 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 25 |
| 5 | Thalidomide Analog [EPC] | 25 |
| 6 | Platinum-based Drug [EPC] | 23 |
| 7 | Topoisomerase Inhibitor [EPC] | 21 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 20 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 25 | 0.0043 |
| 1 | Prostacycline [EPC] | 1 | 0.0011 |
| 2 | BCL-2 Inhibitor [EPC] | 33 | 0.0005 |
| 3 | Proteasome Inhibitor [EPC] | 32 | 0.0003 |
| 4 | Topoisomerase Inhibitor [EPC] | 21 | 0.0003 |
| 5 | Tetracycline-class Drug [EPC] | 13 | 0.0002 |
| 6 | Penem Antibacterial [EPC] | 5 | 0.0001 |
| 7 | Alkylating Drug [EPC] | 31 | 0.0001 |
| 8 | Aminoglycoside Antibacterial [EPC] | 4 | 0.0001 |
| 9 | Platinum-based Drug [EPC] | 23 | 0.0001 |